Results 281 to 290 of about 132,339 (311)
Some of the next articles are maybe not open access.
2004
During the last years it has become obvious that the current way of treating epilepsy with antiepeileptic drugs is insufficient concerning the modification of the underlying disesease and provides merely a symptomatic treatment, without clear influence on the course of the disease.
Péter, Halász, György, Rásonyi
openaire +2 more sources
During the last years it has become obvious that the current way of treating epilepsy with antiepeileptic drugs is insufficient concerning the modification of the underlying disesease and provides merely a symptomatic treatment, without clear influence on the course of the disease.
Péter, Halász, György, Rásonyi
openaire +2 more sources
Glycosaminoglycans and Neuroprotection
2011Glycosaminoglycans (GAGs) are basic building blocks of the ground substance of the extracellular matrix and present at the cellular level as an important component of the glycocalyx covering the cell membrane. In addition to the general role of GAGs in maintaining the integrity of the cell and extracellular matrix by retaining water, certain GAGs ...
B, Dudas, K, Semeniken
openaire +2 more sources
Neuroprotection in Acute Ischemic Stroke: A Brief Review
Canadian Journal of Neurological Sciences, 2022Alastair Buchan, David Pelz
exaly
Neuroprotection for Ischaemic Stroke: Translation From the Bench to the Bedside
International Journal of Stroke, 2012Jens Minnerup +2 more
exaly
Role of Crystallins in Ocular Neuroprotection and Axonal Regeneration
Progress in Retinal and Eye Research, 2014Dirk Bauer +2 more
exaly
Neuroprotection for Ischemic Stroke: Past, Present and Future
Neuropharmacology, 2008Myron D Ginsberg
exaly
Retinal Ganglion Cells and Neuroprotection for Glaucoma
Survey of Ophthalmology, 2003Leonard A Levin
exaly

